Cargando…
Convalescent (immune) plasma treatment in a myelodysplastic COVID-19 patient with disseminated tuberculosis
During the ongoing COVID-19 pandemic due to the SARS-CoV-2 virus of which evidence-based medical paradigms cannot be easily applied; difficult clinical decisions shall be required particularly in the 'difficult-to-treat' cases of high risk group with associated comorbidities. Convalescent...
Autores principales: | Çınar, Olgu Erkin, Sayınalp, Başak, Aladağ Karakulak, Elifcan, Avşar Karataş, Ayşe, Velet, Mustafa, İnkaya, Ahmet Çağkan, Ersoy Ortaç, Nazmiye Ebru, Öcal, Serpil, Aksu, Salih, Haznedaroğlu, İbrahim Celalettin, Sayınalp, Nilgün, Özcebe, Osman İlhami |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7258803/ https://www.ncbi.nlm.nih.gov/pubmed/32487513 http://dx.doi.org/10.1016/j.transci.2020.102821 |
Ejemplares similares
-
The clinical course of COVID-19 in hematopoietic stem cell transplantation (HSCT) recipients
por: KARATAŞ, Ayşe, et al.
Publicado: (2021) -
Efficacy of eltrombopag in thrombocytopenia after hematopoietic stem cell transplantation
por: KARATAŞ, Ayşe, et al.
Publicado: (2022) -
Perspectives for immune plasma treatment of COVID-19
por: SAYINALP, Başak, et al.
Publicado: (2021) -
CD34+ hematopoietic progenitor cell dose as a predictor of engraftment and survival in multiple myeloma patients undergoing autologous stem cell transplantation
por: ALADAĞ, Elifcan, et al.
Publicado: (2020) -
Unclassifiable non-CML classical myeloproliferative diseases with microcytosis: findings indicating diagnosis of polycythemia vera masked by iron deficiency
por: ALADAĞ, Elifcan, et al.
Publicado: (2019)